Background: In 2010, a study estimated the number of smokeless tobacco (SLT) users in 70 countries at 302.4 million. These countries represented 70% of the global population. We aimed to update this information and widen the scope to estimate the global prevalence of SLT use by including a larger number of countries. Methods: Data on the prevalence of current SLT use in 121 countries were obtained from various sources. Country-wise and gender-wise breakdown of the adult population in these countries was derived from the UN World Population for 2015. To translate prevalence rates into an estimate of the number of adult SLT users, we multiplied the adult male and female SLT prevalence rates by the corresponding male and female adult population in the respective countries. We then added the BJMMR, 9(6): 1-20, 2015; Article no.BJMMR.16285 2 estimated number of male and female SLT users to get an overall estimate of SLT use. Results: There were 352 million SLT users (351.9 million) in 121 countries. Of these, 67% were men (232.7 million) and 33% were women (119.2 million). Nearly 95% (333.1 million) of global SLT users lived in developing countries and only 5% (918.8 million) lived in developed countries; 82.7% of global SLT users lived in the World Health Organization (WHO) South-East Asia Region. Globally, 90.4% of SLT users live in 11 countries of the world: India (237.4 million, 67.5%), Bangladesh (30.9 million), Myanmar (12.6 million), Pakistan (10.1 million), USA (9.6 million), China (4.1 million), Indonesia (3.2 million), Nepal (2.7 million), Madagascar (2.6 million), Germany and Uzbekistan (2.4 million each). Conclusion: Smokeless tobacco use is a global epidemic affecting 121 countries. All 180 countries that have ratified the WHO Framework Convention on Tobacco Control (WHO FCTC) are obliged to monitor SLT use. Parties to the Convention should collect information periodically using standard protocols for national and international comparability. To prevent health and economic losses attributable to SLT use, countries, especially developing countries, should formulate strategies specific to SLT control.
INTRODUCTION
In 2010, a study by the National Cancer Institute (NCI) and Centers for Disease Control and Prevention (CDC), USA estimated the number of smokeless tobacco (SLT) users in 70 countries at 302.4 million. These countries represented 70% of the global population [1] . We aimed to update information on the prevalence of SLT use as well as the number of SLT users in 121 countries that contain nearly 90% of the global population in 2015.
METHODS
We obtained data on the prevalence of SLT use from 122 countries from various sources [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] (Web Table 1 ). To estimate the number of SLT users, we used the current prevalence of SLT use from 118 countries, and the prevalence of daily SLT use from three countries (Eritrea, Iceland and Saudi Arabia) for calculation. South Africa reported on the prevalence of ever use of SLT and therefore we excluded it from this study. We included the findings of the latest surveys, and those representing a wide range of ages (15+ years). We used national estimates of prevalence in all cases except for seven countries (Algeria, Chad, Guinea, Sudan, Saint Kitts and Nevis, Lao People's Democratic Republic and Micronesia), for which we used subnational prevalence in absence of national estimates.
To calculate the number of SLT users, we followed the same method as NCI [1] . To translate prevalence rates into an estimate of the number of SLT users among adults, we multiplied the adult male and female prevalence rate of SLT users by the male and female adult populations of the corresponding age group in the respective countries. We added the estimated number of SLT users among men and women to get an overall estimate.
Sample and Coverage
We used country-wise and gender-wise breakdown of the adult population (UN) for the year 2015 to estimate the number of SLT users. [11, 12] Countries included in this study represented nearly 90% (specifically 88.1%) of the world's population (Web Table 1 ). Most of the population in each of the WHO regions was covered; African Region (91.2%), European Region (83.7%), American Region (81.2%), South-East Asia Region (98.7%) and the Western Pacific Region (89.5%). However, the Eastern Mediterranean Region (65.5%) was underrepresented (Web Table 2 ).
The prevalence data are mainly from the Global Adult Tobacco Surveys (22 countries), Demographic Health Surveys (33 countries), STEPS NCD Risk Factor Surveys (30 countries), the special Europe Barometric Surveys (26 countries) and other national surveys (10) (Web Table1).
By age, the prevalence was available for the 15+ years age group in 56 countries, 15-64 years in 16 countries, 15-49 years in 33 countries and 25-64 years in 16 countries (Web Table 1 ).
RESULTS
In 121 countries, there were 351.9 million SLT users (men 232.7 million [67%] and women 119.2 million [33%]) (Web Table 3 ), with the number of users varying greatly across regions and countries ( Fig.1 and Fig. 2 ). Of 352 million SLT users, 333.1 million (94.7%) lived in developing countries and 18.8 million (5.3%) lived in developed countries (Web Table 4 Smokeless tobacco use causes oral, pharyngeal and oesophageal cancer, and heart diseases. Worldwide, the major burden of SLT use is in developing countries, especially those in the South-East Asia and African Regions. This results in greater health and economic losses in developing countries, where SLT contains more tobacco-specific N-nitrosamines (TSNAs) than in developed countries [1] . In India alone, 'all-cause SLT use-attributable mortality' has been estimated to be over 365 000 [16] , the majority among women. Other developing countries with a high burden of SLT use still do not have any information on the health and economic losses attributable to SLT use. Such countries should make efforts to understand the magnitude of the problem and implement specific strategies to combat the menace within their scarce resources.
The estimates in this paper have certain limitations.
(1) Surveys included in this study have not used similar methods and instruments.
(2) The prevalence of SLT use taken for this study is for different years and not uniformly for 2015, and thus assumes that the prevalence has not changed over the years. Some of these data were available for the first time. In case two datasets were available, we used the latest data, or data covering a wider range of age groups. (3) In seven countries, subnational prevalence has been used in the absence of national prevalence estimates. (4) The number of SLT users reported is an underestimation as it represents the number of users aged 15+ years in 56 countries (73.8% of the global population), but underrepresents those in the remaining 65 countries (26.2% of the global population), where the prevalence has been estimated for a limited age range, such as those aged 15-64 years, 15-49 years and 25-64 years.
CONCLUSION
SLT use is a global epidemic spread across 121 countries. All countries that have ratified the WHO FCTC do not have basic information on the prevalence of SLT use. As an obligation of the Treaty, parties to the Convention should collect information on the prevalence of SLT use periodically using standard protocols by integrating TQS in ongoing surveys. The major burden of SLT use is in developing countries with scarce resources. Countries should plan specific strategies to protect their people from the menace of SLT use.
